Publication | Open Access

Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus

MedicineAntiviral Drug DevelopmentEntrance ChannelMolecular BiologyAntiviral TherapyNovel Hiv-1 NnrtisAntiviral DrugHivPharmacologyAntiviral CompoundDiarylnicotinamide 1,4-Disubstituted 1,2,3-TriazolesDrug Discovery